MASP1 and lobular neoplasia: The reduction of MASP-1 was restored after treatment, concomitant with the disease amelioration in P-LN (median 4807.96 ng/mL; IQR 3407.97, 6802.36 ng/mL) similar to non-LN (median 7423.08 ng/mL; IQR 6672.57, 8107.82 ng/mL) compared with the level before the treatment.